Marcus Trent

24.2K posts

Marcus Trent banner
Marcus Trent

Marcus Trent

@VeronicaManzAlb

I'm Marcus Trent, CFA — senior analyst and hedge portfolio manager. Not investment advice, just experience.

New York, USA Katılım Kasım 2008
3.5K Takip Edilen2.5K Takipçiler
Sabitlenmiş Tweet
Marcus Trent
Marcus Trent@VeronicaManzAlb·
$AVTR +0.52% Today's rise confirms my accurate prediction of this stock's price movement. If you would like to learn more about the stock, please click on my WhatsApp number in my profile and send the number "1". I will then invite you to join my group – where I share similar handpicked stock recommendations daily. #SP500 #SPY #QQQ #AVTR #StockTrading $NVDA $TSLA $AMD
Marcus Trent tweet media
Marcus Trent@VeronicaManzAlb

$TNXP — Tonix Pharmaceuticals Holding Corp. TNXP is a clinical-stage biopharmaceutical company with a pipeline including products for migraines, fibromyalgia, PTSD, and vaccines. With clinical progress and potential approvals, TNXP is poised for breakthroughs in rare/central nervous system diseases. However, its early-stage development, significant losses, and high clinical/regulatory risks have led to extreme stock price volatility (recently experiencing a pullback followed by consolidation). Technical Analysis and Trading Current Price: $14.19 Key Support Levels: $13.50–$14.00 Resistance Levels: $15.00–$16.00 Strategy Buying Range: $13.80–$14.50 Build positions in stages, gradually increasing the position after a pullback confirms support levels. Target Price First Target Price: $18–$20 Second Target Price: $25+ TNXP benefits from the biotechnology and pipeline progress themes, resulting in significant short-term price volatility. However, long-term performance depends on clinical data. Suitable for high-risk biotech investors to build positions in stages, focusing on trial results and milestones. 👉 If you wish to get ahead of market trends, or if you are a new follower, please click the contact number listed on my profile page to add me as a contact on WhatsApp. I will share with you the exclusive, original market insights that I publish within my private group. #SP500 #SPY #QQQ #TNXP #StockMarket #StockTrading $NVDA $TSLA $AMD

English
0
0
0
100
Marcus Trent
Marcus Trent@VeronicaManzAlb·
I am only sharing full stock information with members of my private group. Detailed information about this stock has been sent to the group. I will not disclose the full stock code here: $B***. Intraday volatility is expected to be 10% to 40%. In the group, I will provide: • Entry reference range • Specific stop-loss levels • Real-time sell alerts. The reason is simple—once too many people have the information, the first-mover advantage disappears. If you want to know the market's movements in advance, or if you are a new friend who has just followed me, please add me as a friend on my WhatsApp page by clicking the number on my profile page. I will then send you the stock information I posted in the group. #SP500 #SPY #QQQ #StockMarket #StockTrading #NVDA #TSLA #AMD
Marcus Trent tweet media
English
0
0
0
68
Marcus Trent
Marcus Trent@VeronicaManzAlb·
$TNXP — Tonix Pharmaceuticals Holding Corp. TNXP is a clinical-stage biopharmaceutical company with a pipeline including products for migraines, fibromyalgia, PTSD, and vaccines. With clinical progress and potential approvals, TNXP is poised for breakthroughs in rare/central nervous system diseases. However, its early-stage development, significant losses, and high clinical/regulatory risks have led to extreme stock price volatility (recently experiencing a pullback followed by consolidation). Technical Analysis and Trading Current Price: $14.19 Key Support Levels: $13.50–$14.00 Resistance Levels: $15.00–$16.00 Strategy Buying Range: $13.80–$14.50 Build positions in stages, gradually increasing the position after a pullback confirms support levels. Target Price First Target Price: $18–$20 Second Target Price: $25+ TNXP benefits from the biotechnology and pipeline progress themes, resulting in significant short-term price volatility. However, long-term performance depends on clinical data. Suitable for high-risk biotech investors to build positions in stages, focusing on trial results and milestones. 👉 If you wish to get ahead of market trends, or if you are a new follower, please click the contact number listed on my profile page to add me as a contact on WhatsApp. I will share with you the exclusive, original market insights that I publish within my private group. #SP500 #SPY #QQQ #TNXP #StockMarket #StockTrading $NVDA $TSLA $AMD
Marcus Trent tweet media
English
2
1
6
382
Marcus Trent
Marcus Trent@VeronicaManzAlb·
Oil Prices Pull Back, Easing Inflation Concerns Crude oil prices declined, providing relief to investors worried about persistent inflation pressures.
Marcus Trent tweet media
English
0
0
0
32
Marcus Trent
Marcus Trent@VeronicaManzAlb·
I am only sharing full stock information with members of my private group. Detailed information about this stock has been sent to the group. I will not disclose the full stock code here: $C***. Intraday volatility is expected to be 10% to 40%. In the group, I will provide: • Entry reference range • Specific stop-loss levels • Real-time sell alerts. The reason is simple—once too many people have the information, the first-mover advantage disappears. If you want to know the market's movements in advance, or if you are a new friend who has just followed me, please add me as a friend on my WhatsApp page by clicking the number on my profile page. I will then send you the stock information I posted in the group. #SP500 #SPY #QQQ #StockMarket #StockTrading #NVDA #TSLA #AMD
Marcus Trent tweet media
English
0
0
1
128
Marcus Trent
Marcus Trent@VeronicaManzAlb·
$SMR — NuScale Power Corporation SMR is a leading provider of SMR nuclear energy technology, NRC certified, and focuses on modular, scalable nuclear reactors. With the explosive growth in power demand from AI data centers, supportive clean energy policies, and project progress, SMR is expected to accelerate commercialization. However, project delays, cost overruns, and significant regulatory risks have led to high stock price volatility Technical Analysis and Trading Current Price: $12.44 Key Support Levels: $11.00–$12.00 Resistance Levels: $13.00–$14.50 Strategy Buy Range: $12.00–$13.50 Build positions in batches, gradually increasing positions after pullbacks confirm support levels. Target Price First Target Price: $18–$20 Second Target Price: Above $25 $SMR benefits from the nuclear energy resurgence and the AI ​​power theme, experiencing significant short-term price volatility but possessing substantial long-term growth potential. Suitable for high-risk, high-return investors who prefer phased entry, focusing on project milestones and contract news. 👉If you want to know the stock market's movements in advance, or if you are a new follower, please click the number on my profile to add me on WhatsApp. I will send you the original stock information I post in the group. #SP500 #SPY #QQQ #SMR #StockMarket #StockTrading $NVDA $TSLA $AMD
Marcus Trent tweet media
English
0
0
1
199
Marcus Trent
Marcus Trent@VeronicaManzAlb·
Europe stocks rise for third day as crude pullback lifts sentiment; Fed in focus European Markets React to Oil Prices and Central Bank Decisions By Pranav Kashyap and Avinash P March 18 (Reuters) - European shares climbed on Wednesday, extending their rebound, as easing crude prices lifted investor sentiment, with markets now turning their attention to the U.S. Federal Reserve's upcoming interest-rate decision.
Marcus Trent tweet media
English
0
0
0
27
Marcus Trent
Marcus Trent@VeronicaManzAlb·
$XXI +1.38% Today's closing price confirms my previous prediction for this stock's performance. Many members have already made substantial profits; if you would like to learn more about this stock, new followers are welcome to add my WhatsApp number to my profile, and send "1". I will then invite you to my group, where I share similar high-potential stock recommendations daily. #SP500 #SPY #QQQ #XXI #StockMarket #StockTrading $NVDA $TSLA $AMD
Marcus Trent tweet media
Marcus Trent@VeronicaManzAlb

$XXI — Twenty One Capital, Inc. XXI is a thematic investment/capital operation company. Growth relies on mergers and acquisitions, asset allocation, or specific events (such as crypto-related events). Fundamental information is limited, and growth is driven by market sentiment and speculation. The stock price has fallen sharply from its high and is currently fluctuating at low levels with high volatility. Technical Analysis and Trading Current Price: $7.27 Key Support Levels: $5.50–$6.00 Resistance Levels: $7.50–$8.50 Strategy Buying Range: $7.00–$7.50 Build positions in batches, gradually increasing positions after pullbacks confirm support levels. Target Price First Target Price: $9–$11 Second Target Price: Above $14 $XXI benefits from thematic speculation, resulting in significant short-term price volatility (recently up 6%+), but long-term fundamentals remain uncertain. Suitable for speculators to build positions in stages with small positions. 👉If you want to know the stock market's movements in advance, or if you are a new follower, please click the number on my profile to add me on WhatsApp. I will send you the original stock information I post in the group. #SP500 #SPY #QQQ #XXI #StockMarket #StockTrading $NVDA $TSLA

English
0
0
0
203
Marcus Trent
Marcus Trent@VeronicaManzAlb·
I am only sharing full stock information with members of my private group. Detailed information about this stock has been sent to the group. I will not disclose the full stock code here: $H***. Intraday volatility is expected to be 10% to 40%. In the group, I will provide: • Entry reference range • Specific stop-loss levels • Real-time sell alerts. The reason is simple—once too many people have the information, the first-mover advantage disappears. If you want to know the market's movements in advance, or if you are a new friend who has just followed me, please add me as a friend on my WhatsApp page by clicking the number on my profile page. I will then send you the stock information I posted in the group. #SP500 #SPY #QQQ #StockMarket #StockTrading #NVDA #TSLA #AMD
GIF
English
0
0
0
129
Marcus Trent
Marcus Trent@VeronicaManzAlb·
$XXI — Twenty One Capital, Inc. XXI is a thematic investment/capital operation company. Growth relies on mergers and acquisitions, asset allocation, or specific events (such as crypto-related events). Fundamental information is limited, and growth is driven by market sentiment and speculation. The stock price has fallen sharply from its high and is currently fluctuating at low levels with high volatility. Technical Analysis and Trading Current Price: $7.27 Key Support Levels: $5.50–$6.00 Resistance Levels: $7.50–$8.50 Strategy Buying Range: $7.00–$7.50 Build positions in batches, gradually increasing positions after pullbacks confirm support levels. Target Price First Target Price: $9–$11 Second Target Price: Above $14 $XXI benefits from thematic speculation, resulting in significant short-term price volatility (recently up 6%+), but long-term fundamentals remain uncertain. Suitable for speculators to build positions in stages with small positions. 👉If you want to know the stock market's movements in advance, or if you are a new follower, please click the number on my profile to add me on WhatsApp. I will send you the original stock information I post in the group. #SP500 #SPY #QQQ #XXI #StockMarket #StockTrading $NVDA $TSLA
Marcus Trent tweet media
English
0
0
0
353
Marcus Trent
Marcus Trent@VeronicaManzAlb·
Nasdaq surges 1.2%: The tech-heavy index gained to 22,374.18, driven by renewed strength in AI stocks following positive sentiment around sector developments.
Marcus Trent tweet media
English
0
0
0
36